+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Skin, Drug Research), End user (Biopharma, Academia) - Global Forecast to 2024

  • ID: 4846742
  • Report
  • Region: Global
  • 184 Pages
  • Markets and Markets
1 of 6
The 3D Bioprinting Market is Projected to Grow at a CAGR of 20.4% During the Forecast Period

FEATURED COMPANIES

  • Allevi Inc.
  • Cellink
  • Digilab, Inc.
  • Gesim
  • Organovo Holdings, Inc.
  • Regenhu
  • MORE

The 3D bioprinting market is projected to reach USD 1,647 million by 2024 from USD 651 million in 2019, at a CAGR of 20.4% from 2019 to 2024. The growth in this market is mainly driven by technological advancements in 3D bioprinters and biomaterials, increasing the use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities. On the other hand, a shortage of skilled professionals and high development and production costs are hampering the growth of this market.

Microextrusion technology commanded the largest share of 3D bioprinters segment owing to technological advancements

The component segment of the 3D bioprinting market is segmented into 3D bioprinters and bioinks. The 3D bioprinters market is further sub-segmented on the basis of technology into magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting, microextrusion bioprinting, and other technologies; whereas bioinks segment is further sub-segmented into natural, synthetic, and hybrid bioinks. The microextrusion bioprinting technology has commanded the largest share of the market in 2019 due to technological advancements in the segment and the increasing research activities.

The drug discovery research application segment accounted for the largest share of the 3D bioprinting market in 2019

In terms of applications, the 3D bioprinting market is segmented into research applications and clinical applications. The demand for research applications is further sub-segmented into drug research, regenerative medicine, and 3D cell culture. Among these, the drug research segment accounted for the largest share of the market in 2019, owing to the growing adoption of 3D bioprinting technology by biopharmaceutical companies. While, in terms of clinical applications, the market is segmented into skin, bone & cartilage, blood vessels, and other clinical applications.

Based on material, living cells segment commanded the leading market share in 2019

Based on material, the 3D bioprinting market is broadly segmented into hydrogels, extracellular matrices, living cells, and other biomaterials. Increasing R&D activities for the use of living cells in 3D bioprinting is driving the growth of the living cells segment. Living cells have the ability to fabricate patient-specific tissues in a defined manner. With advances in 3D bioprinting, scientists and researchers are making use of living cells as a biomaterial in 3D bioprinting. These cells can be used to print living tissues as well as organ structures for surgical implantations. However, ethical issues associated with the use of stem cells in 3D bioprinting might hamper the growth of the segment.

The US 3D bioprinting market to hold prominent market share over the forecast period

On the basis of region, the 3D bioprinting market is segmented into North America, Europe, Asia Pacific, and Rest of the World (Latin America, and the Middle East and Africa). The US held a significant share of the global 3D bioprinting market in 2019. Factors such as new product launches and technological advancements in 3D bioprinting technology and the presence of key players in the region are driving the growth of the 3D bioprinting market in the US. Moreover, extensive research activities and funding for 3D bioprinting will further fuel the market growth in the US.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 - 45%, Tier 2 - 35%, and Tier 3 - 20%
  • By Designation: C-level - 26%, Director-level - 30%, and Others - 44%
  • By Region: North America- 34%, Europe - 26%, APAC - 23%, and RoW - 17%

The major players in the market include Organovo Holdings Inc. (US), CELLINK (Sweden), Allevi Inc. (US), Aspect Biosystems Ltd. (Canada), EnvisionTEC GmbH (Germany), Cyfuse Biomedical K.K. (Japan), Poietis (France), TeVido BioDevices (US), Nano3D Biosciences, Inc. (US), ROKIT Healthcare (South Korea), Digilab Inc. (US), regenHU (Switzerland), GeSiM (Germany), Advanced Solutions Life Sciences (US), and Regenovo Biotechnology Co., Ltd. (China) among others.

Research Coverage
This report studies the 3D bioprinting market based on component, application, material, end-user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning individual growth trends, and it also forecasts the revenue of the market segments for four main regions.

Key Benefits of Buying the Report
This report focuses on various levels of analysis - industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; and high-growth countries along with their respective drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Allevi Inc.
  • Cellink
  • Digilab, Inc.
  • Gesim
  • Organovo Holdings, Inc.
  • Regenhu
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations

3 Executive Summary

4 Premium Insights
4.1 3D Bioprinting Market Overview
4.2 Market Share, By Component and Region
4.3 Market, By Material, 2019 vs 2024 (USD Million)
4.4 Market, By End User, 2019 vs 2024 (USD Million)
4.5 Geographic Snapshot of the Market

5 Market Overview
5.1 Introduction
5.2 3D Bioprinting Approaches
5.2.1 Biomimicry
5.2.2 Autonomous Self-Assembly
5.2.3 Mini-Tissue Building Blocks
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Use of 3D Bioprinting in the Pharmaceutical and Cosmetology Industries
5.3.1.2 Rising Public and Private Funding to Support Bioprinting Research Activities
5.3.1.3 Technological Advancements in the 3D Bioprinting Industry
5.3.2 Restraints
5.3.2.1 Dearth of Skilled Professionals
5.3.2.2 High Development & Production Costs
5.3.2.3 Lack of Regulatory Guidelines Governing 3D Bioprinting
5.3.3 Opportunities
5.3.3.1 Rising Demand for Organ Transplants
5.3.3.2 Growing Awareness of 3D Bioprinting
5.3.3.3 Growing Demand for Regenerative Medicine & Stem Cell Research
5.3.4 Challenges
5.3.4.1 Socioethical Concerns Related to the Use of 3D Bioprinted Products
5.3.4.2 High Cost of 3D Bioprinting
5.3.4.3 Process Control & Understanding

6 3D Bioprinting Market, By Component
6.1 Introduction
6.2 3D Bioprinters
6.2.1 3D Bioprinters Market, By Technology
6.2.1.1 Microextrusion Bioprinting
6.2.1.1.1 Increasing Research in the Field of Microextrusion is Fueling the Adoption of This Technology
6.2.1.2 Inkjet 3D Bioprinting
6.2.1.2.1 High Cell Viability and Low Cost have Resulted in the Increased Demand for Inkjet 3D Bioprinting
6.2.1.3 Laser-Assisted Bioprinting
6.2.1.3.1 Laser-Assisted Bioprinting is One of the Highest-Resolution Bioprinting Technologies Available in the 3D Bioprinting Industry
6.2.1.4 Magnetic 3D Bioprinting
6.2.1.4.1 Accuracy and Speed in the Formation and Processing of Cultured Tissues are the Major Advantages Associated With Magnetic 3D Bioprinting
6.2.1.5 Other Technologies
6.3 Bioinks
6.3.1 Natural Bioinks
6.3.1.1 Natural Bioinks are the Most Commonly Preferred Bioinks in the 3D Bioprinting Process
6.3.2 Hybrid Bioinks
6.3.2.1 Hybrid Bioinks Possess High Mechanical Strength and Great Biocompatibility
6.3.3 Synthetic Bioinks
6.3.3.1 Improved Mechanical Strength and Consistency Offered By Synthetic Bioinks to Drive Market Growth

7 3D Bioprinting Market, By Material
7.1 Introduction
7.2 Living Cells
7.2.1 Ethical Issues Associated With the Use of Living Cells in Organ Development to Hamper Market Growth
7.3 Hydrogels
7.3.1 Dynamic Properties of Hydrogels are Supporting Their Increased Use in 3D Tissue Engineering and Biomedical Applications
7.4 Extracellular Matrices
7.4.1 Ecm has Emerged as A Promising Tool in Tissue Engineering
7.5 Other Biomaterials

8 3D Bioprinting Market, By Application
8.1 Introduction
8.2 Research Applications
8.2.1 Drug Research
8.2.1.1 Drug Research Segment to Register the Highest Growth During the Forecast Period
8.2.2 Regenerative Medicine
8.2.2.1 Growing Demand for Organ Transplants to Support Market Growth
8.2.3 3D Cell Culture
8.2.3.1 Rising Focus on Developing Alternatives to Animal Testing to Support Market Growth
8.3 Clinical Applications
8.3.1 Skin
8.3.1.1 Growing Number of Aesthetic and Reconstruction Surgeries to Propel Market Growth
8.3.2 Bone & Cartilage
8.3.2.1 Increasing Incidence of Musculoskeletal Conditions to Drive the Demand for Bone Grafts
8.3.3 Blood Vessels
8.3.3.1 Increasing Research Activities Focused on the 3D Bioprinting of Blood Vessels is the Major Factor Driving Market Growth
8.3.4 Other Clinical Applications

9 3D Bioprinting Market, By End User
9.1 Introduction
9.2 Research Organizations & Academic Institutes
9.2.1 Research Organizations & Academic Institutes are the Fastest-Growing End Users of 3D Bioprinting
9.3 Biopharmaceutical Companies
9.3.1 Increasing Prevalence of Chronic Diseases to Drive the Adoption of 3D Bioprinting Among Biopharmaceutical Companies
9.4 Hospitals
9.4.1 3D Printing Offers A Customized Surgical Planning Tool for Hospitals

10 3D Bioprinting Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 The US Dominates the Global Market
10.2.2 Canada
10.2.2.1 Government Initiatives to Support the Growth of the Market in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Increasing Demand for Organ Transplants to Drive Market Growth
10.3.2 UK
10.3.2.1 Increase in Funding and Grants to Support Research Activities Related to 3D Bioprinting in the UK
10.3.3 France
10.3.3.1 Growing Cosmetics Industry in France to Propel the Adoption of 3D Bioprinting Technologies
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Strong Research Base and Government Support to Drive the Growth of the Market in Japan
10.4.2 China
10.4.2.1 The Market in China is Projected to Register Significant Growth Owing to Rising Regenerative Medicine Research
10.4.3 India
10.4.3.1 Initiatives to Raise Awareness and Develop Novel Products to Support Market Growth in India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
10.5.1 Latin America
10.5.1.1 Growing Medical Tourism to Contribute to the Growth of the Market in the Region
10.5.2 Middle East & Africa
10.5.2.1 Lack of Awareness and Underdeveloped Infrastructure to Hamper Market Growth

11 Competitive Landscape
11.1 Introduction
11.2 Market Ranking Analysis
11.3 Competitive Scenario
11.4 Competitive Leadership Mapping
11.5 Vendor Inclusion Criteria
11.6 Vendor Dive
11.6.1 Visionary Leaders
11.6.2 Innovators
11.6.3 Dynamic Differentiators
11.6.4 Emerging Companies

12 Company Profiles
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 Advanced Solutions Life Sciences
12.2 Allevi Inc.
12.3 Aspect Biosystems Ltd.
12.4 Cellink
12.5 Cyfuse Biomedical K.K.
12.6 Digilab, Inc.
12.7 Envisiontec
12.8 Gesim
12.9 Nano3D Biosciences, Inc.
12.10 Organovo Holdings, Inc.
12.11 Poietis
12.12 Regenhu
12.13 Regenovo Biotechnology Co., Ltd.
12.14 Rokit Healthcare
12.15 Tevido Biodevices

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

List of Tables
Table 1 3D Bioprinting Market, By Component, 2017–2024 (USD Million)
Table 2 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 3 3D Bioprinters Market, By Region, 2017–2024 (USD Million)
Table 4 Microextrusion Bioprinting Market, By Region, 2017–2024 (USD Million)
Table 5 Inkjet Market, By Region, 2017–2024 (USD Million)
Table 6 Laser-Assisted Bioprinting Market, By Region, 2017–2024 (USD Million)
Table 7 Magnetic 3D Bioprinting Market, By Region, 2017–2024 (USD Million)
Table 8 3D Bioprinters Market for Other Technologies, By Region, 2017–2024 (USD Million)
Table 9 Bioinks Market, By Type, 2017–2024 (USD Million)
Table 10 Bioinks Market, By Region, 2017–2024 (USD Million)
Table 11 Natural Bioinks Market, By Region, 2017–2024 (USD Million)
Table 12 Hybrid Bioinks Market, By Region, 2017–2024 (USD Million)
Table 13 Synthetic Bioinks Market, By Region, 2017–2024 (USD Million)
Table 14 Market, By Material, 2017–2024 (USD Million)
Table 15 Market for Living Cells, By Region, 2017–2024 (USD Million)
Table 16 Market for Hydrogels, By Region, 2017–2024 (USD Million)
Table 17 Market for Extracellular Matrices, By Region, 2017–2024 (USD Million)
Table 18 Market for Other Biomaterials, By Region, 2017–2024 (USD Million)
Table 19 Market, By Application, 2017–2024 (USD Million)
Table 20 Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 21 Market for Research Applications, By Region, 2017–2024 (USD Million)
Table 22 Market for Drug Research, By Region, 2017–2024 (USD Million)
Table 23 Market for Regenerative Medicine, By Region, 2017–2024 (USD Million)
Table 24 Market for 3D Cell Culture, By Region, 2017–2024 (USD Million)
Table 25 Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 26 Market for Clinical Applications, By Region, 2017–2024 (USD Million)
Table 27 Market for Skin Printing Applications, By Region, 2017–2024 (USD Million)
Table 28 3D Bioprinting Market for Bone & Cartilage Printing Applications, By Region, 2017–2024 (USD Million)
Table 29 Market for Blood Vessel Printing Applications, By Region, 2017–2024 (USD Million)
Table 30 List of Ongoing Clinical Trials
Table 31 Market for Other Clinical Applications, By Region, 2017–2024 (USD Million)
Table 32 Market, By End User, 2017–2024 (USD Million)
Table 33 Market for Research Organizations & Academic Institutes, By Region, 2017–2024 (USD Million)
Table 34 Market for Biopharmaceutical Companies, By Region, 2017–2024 (USD Million)
Table 35 Market for Hospitals, By Region, 2017–2024 (USD Million)
Table 36 Market, By Region, 2017–2024 (USD Million)
Table 37 North America: 3D Bioprinting Market, By Country, 2017–2024 (USD Million)
Table 38 North America: Market, By Component, 2017–2024 (USD Million)
Table 39 North America: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 40 North America: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 41 North America: Market, By Application, 2017–2024 (USD Million)
Table 42 North America: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 43 North America: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 44 North America: Market, By Material, 2017–2024 (USD Million)
Table 45 North America: Market, By End User, 2017–2024 (USD Million)
Table 46 US: Market, By Component, 2017–2024 (USD Million)
Table 47 US: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 48 US: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 49 US: Market, By Application, 2017–2024 (USD Million)
Table 50 US: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 51 US: 3D Bioprinting Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 52 US: Market, By Material, 2017–2024 (USD Million)
Table 53 US: Market, By Component, 2017–2024 (USD Million)
Table 55 Canada: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 56 Canada: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 57 Canada: Market, By Application, 2017–2024 (USD Million)
Table 58 Canada: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 59 Canada: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 60 Canada: Market, By Material, 2017–2024 (USD Million)
Table 61 Canada: Market, By End User, 2017–2024 (USD Million)
Table 62 Europe: Market, By Country, 2017–2024 (USD Million)
Table 63 Europe: Market, By Component, 2017–2024 (USD Million)
Table 64 Europe: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 65 Europe: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 66 Europe: Market, By Application, 2017–2024 (USD Million)
Table 67 Europe: 3D Bioprinting Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 68 Europe: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 69 Europe: Market, By Material, 2017–2024 (USD Million)
Table 70 Europe: Market, By End User, 2017–2024 (USD Million)
Table 71 Germany: Market, By Component, 2017–2024 (USD Million)
Table 72 Germany: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 73 Germany: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 74 Germany: Market, By Application, 2017–2024 (USD Million)
Table 75 Germany: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 76 Germany: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 77 Germany: Market, By Material, 2017–2024 (USD Million)
Table 78 Germany: Market, By End User, 2017–2024 (USD Million)
Table 79 UK: Market, By Component, 2017–2024 (USD Million)
Table 80 UK: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 81 UK: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 82 UK: Market, By Application, 2017–2024 (USD Million)
Table 83 UK: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 84 UK: 3D Bioprinting Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 85 UK: Market, By Material, 2017–2024 (USD Million)
Table 86 UK: Market, By End User, 2017–2024 (USD Million)
Table 87 France: Market, By Component, 2017–2024 (USD Million)
Table 88 France: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 89 France: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 90 France: Market, By Application, 2017–2024 (USD Million)
Table 91 France: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 92 France: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 93 France: Market, By Material, 2017–2024 (USD Million)
Table 94 France: Market, By End User, 2017–2024 (USD Million)
Table 95 RoE: Market, By Component, 2017–2024 (USD Million)
Table 96 RoE: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 97 RoE: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 98 RoE: Market, By Application, 2017–2024 (USD Million)
Table 99 RoE: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 100 RoE: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 101 RoE: Market, By Material, 2017–2024 (USD Million)
Table 102 RoE: Market, By End User, 2017–2024 (USD Million)
Table 103 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 104 Asia Pacific: Market, By Component, 2017–2024 (USD Million)
Table 105 Asia Pacific: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 106 Asia Pacific: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 107 Asia Pacific: Market, By Application, 2017–2024 (USD Million)
Table 108 Asia Pacific: 3D Bioprinting Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 109 Asia Pacific: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 110 Asia Pacific: Market, By Material, 2017–2024 (USD Million)
Table 111 Asia Pacific: Market, By End User, 2017–2024 (USD Million)
Table 112 Japan: Market, By Component, 2017–2024 (USD Million)
Table 113 Japan: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 114 Japan: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 115 Japan: Market, By Application, 2017–2024 (USD Million)
Table 116 Japan: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 117 Japan: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 118 Japan: Market, By Material, 2017–2024 (USD Million)
Table 119 Japan: Market, By End User, 2017–2024 (USD Million)
Table 120 China: Market, By Component, 2017–2024 (USD Million)
Table 121 China: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 122 China: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 123 China: 3D Bioprinting Market, By Application, 2017–2024 (USD Million)
Table 124 China: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 125 China: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 126 China: Market, By Material, 2017–2024 (USD Million)
Table 127 China: Market, By End User, 2017–2024 (USD Million)
Table 128 India: Market, By Component, 2017–2024 (USD Million)
Table 129 India: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 130 India: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 131 India: Market, By Application, 2017–2024 (USD Million)
Table 132 India: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 133 India: 3D Bioprinting Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 134 India: Market, By Material, 2017–2024 (USD Million)
Table 135 India: Market, By End User, 2017–2024 (USD Million)
Table 136 RoAPAC: Market, By Component, 2017–2024 (USD Million)
Table 137 RoAPAC: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 138 RoAPAC: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 139 RoAPAC: Market, By Application, 2017–2024 (USD Million)
Table 140 RoAPAC: 3D Bioprinting Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 141 RoAPAC: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 142 RoAPAC: Market, By Material, 2017–2024 (USD Million)
Table 143 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 144 Rest of the World: Market, By Region, 2017–2024 (USD Million)
Table 145 Rest of the World: 3D Bioprinting Market, By Component, 2017–2024 (USD Million)
Table 146 Rest of the World: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 147 Rest of the World: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 148 Rest of the World: Market, By Application, 2017–2024 (USD Million)
Table 149 Rest of the World: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 150 Rest of the World: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 151 Rest of the World: Market, By Material, 2017–2024 (USD Million)
Table 152 Rest of the World: Market, By End User, 2017–2024 (USD Million)
Table 153 Latin America: Market, By Component, 2017–2024 (USD Million)
Table 154 Latin America: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 155 Latin America: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 156 Latin America: Market, By Application, 2017–2024 (USD Million)
Table 157 Latin America: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 158 Latin America: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 159 Latin America: Market, By Material, 2017–2024 (USD Million)
Table 160 Latin America: Market, By End User, 2017–2024 (USD Million)
Table 161 Middle East & Africa: Market, By Component, 2017–2024 (USD Million)
Table 162 Middle East & Africa: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 163 Middle East & Africa: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 164 Middle East & Africa: Market, By Application, 2017–2024 (USD Million)
Table 165 Middle East & Africa: 3D Bioprinting Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 166 Middle East & Africa: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 167 Middle East & Africa: Market, By Material, 2017–2024 (USD Million)
Table 168 Middle East & Africa: Market, By End User, 2017–2024 (USD Million)
Table 169 Product Launches & Approvals
Table 170 Collaborations
Table 171 Expansions
Table 172 Acquisitions

List of Figures
Figure 1 3D Bioprinting Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primaries
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Market Size Estimation: Overall 3D Bioprinting Market
Figure 6 Data Triangulation Methodology
Figure 7 Market Share, By Component, 2019 vs 2024
Figure 8 Market, By Application, 2019 vs 2024 (USD Million)
Figure 9 Market Share, By Material, 2019 vs 2024
Figure 10 Market, By End User, 2019 vs 2024 (USD Million)
Figure 11 Geographical Snapshot of the Market
Figure 12 Technological Advancements in 3D Bioprinters and Biomaterials to Drive Market Growth
Figure 13 North America is the Largest Regional Market for 3D Bioprinters and Bioinks
Figure 14 Living Cells Segment to Hold the Major Share of the Market During the Forecast Period
Figure 15 Research Organizations & Academic Institutes Will Register the Highest CAGR During the Forecast Period
Figure 16 China to Register the Highest CAGR During the Forecast Period
Figure 17 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 North America: Market Snapshot
Figure 19 Europe: Market Snapshot
Figure 20 Asia Pacific: Market Snapshot
Figure 21 Global Market Ranking, By Key Player, 2018
Figure 22 Competitive Leadership Mapping (Overall Market), 2018
Figure 23 Competitive Leadership Mapping (SME/Start-UPS), 2018
Figure 24 Cellink: Company Snapshot
Figure 25 Organovo Holdings, Inc.: Company Snapshot

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Advanced Solutions Life Sciences
  • Allevi Inc.
  • Aspect Biosystems Ltd.
  • Cellink
  • Cyfuse Biomedical K.K.
  • Digilab, Inc.
  • Envisiontec
  • Gesim
  • Nano3D Biosciences, Inc.
  • Organovo Holdings, Inc.
  • Poietis
  • Regenhu
  • Regenovo Biotechnology Co., Ltd.
  • Rokit Healthcare
  • Tevido Biodevices
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll